Funder
National Institutes of Health
CA
University at Buffalo - Novartis Fellowship
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference54 articles.
1. Institute NC (2018) Surveillance, Epidemiology, and End Results (SEER) Program
2. Buchner T, Berdel WE, Haferlach C, Haferlach T, Schnittger S, Muller-Tidow C et al (2009) Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the german acute myeloid leukemia cooperative group. J Clin Oncol 27(1):61–69
3. Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D et al (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 113(18):4179–4187
4. Rees JK, Gray RG, Swirsky D, Hayhoe FG (1986) Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet 2(8518):1236–1241
5. Estey E, Smith TL, Keating MJ, McCredie KB, Gehan EA, Freireich EJ (1989) Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia 3(4):257–263
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献